BLFS - BioLife Solutions, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$29.60
DETAILS
HIGH:
$34.00
LOW:
$22.00
MEDIAN:
$30.00
CONSENSUS:
$29.60
DOWNSIDE:
1.00%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 64.6% |
| EBIT Margin | -1.1% |
| EBITDA Margin | 3.7% |
| Operating Margin | -1.1% |
| Pretax Margin | -12.6% |
| Cont. Ops Margin | -12.6% |
| Net Margin | -12.6% |
| Bottom Line Margin | -12.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.94 |
| Quick Ratio | 4.63 |
| Solvency Ratio | -0.219 |
| Cash Ratio | 1.44 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-96.72
Peers avg: 39.9
|
| PEG Ratio | 2.24 |
| Forward PEG | 2.24 |
| Price/Book | 3.10 |
| Price/Sales | 12.00 |
| Price/FCF | 2775.69 |
| Price/Op Cash Flow | 57.40 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0441 |
| Debt/Equity | 0.0481 |
| Debt/Capital | 0.0459 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.09 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.84 |
| Operating Cash Flow Ratio | 0.875 |
| Operating Cash Flow/Sales | 20.9% |
| Free Cash Flow/Operating Cash Flow | 2.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.46 |
| Interest Coverage | -0.3995 |
| Short-Term Operating Cash Flow Coverage | 4.03 |
| Operating Cash Flow Coverage | 1.12 |
| Capital Expenditure Coverage | 1.02 |
| Dividend + Capital Expenditure Coverage | 1.02 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.01 |
| EPS | -0.254 |
| Debt/Share | 0.4314 |
| Cash/Share | 1.86 |
| Book Value/Share | 7.79 |
| Tangible BV/Share | 3.33 |
| Equity/Share | 7.79 |
| Operating Cash Flow/Share | 0.421 |
| Capital Expenditure/Share | 0.413 |
| FCF/Share | 0.009 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.004 |
| Earnings Before Tax/EBIT | 11.176 |
| Price/Fair Value | 3.10 |
| Debt/Market Cap | 0.0043 |
| Effective Tax Rate | -0.4% |
| Enterprise Value Multiple | 316.01 |